4.7 Review

Automation and data-driven design of polymer therapeutics

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 171, Issue -, Pages 1-28

Publisher

ELSEVIER
DOI: 10.1016/j.addr.2020.11.009

Keywords

Polymer chemistry; High throughput screening; Automation; Machine learning; Drug delivery; Gene delivery

Funding

  1. National Institutes of General Medical Sciences of the National Institutes of Health [T32GM008339]
  2. New Jersey Commission on Cancer Research (NJCCR) Pre-Doctoral Research Fellowship under the New Jersey Department of Health
  3. NIH [K12GM093854]
  4. NSF CBET [2009942]
  5. Div Of Chem, Bioeng, Env, & Transp Sys
  6. Directorate For Engineering [2009942] Funding Source: National Science Foundation

Ask authors/readers for more resources

Researchers utilize tunable structural parameters of polymers for drug delivery and biomaterial applications, employing intelligent and big data approaches to maximize experimental efficiency. Machine learning and artificial intelligence technologies may play a crucial role in this field.
Polymers are uniquely suited for drug delivery and biomaterial applications due to tunable structural parameters such as length, composition, architecture, and valency. To facilitate designs, researchers may explore combinatorial libraries in a high throughput fashion to correlate structure to function. However, traditional polymerization reactions including controlled living radical polymerization (CLRP) and ring-opening polymerization (ROP) require inert reaction conditions and extensive expertise to implement. With the advent of air-tolerance and automation, several polymerization techniques are now compatible with well plates and can be carried out at the benchtop, making high throughput synthesis and high throughput screening (HTS) possible. To avoid HTS pitfalls often described as fishing expeditions, it is crucial to employ intelligent and big data approaches to maximize experimental efficiency. This is where the disruptive technologies of machine learning (ML) and artificial intelligence (AI) will likely play a role. In fact, ML and AI are already impacting small molecule drug discovery and showing signs of emerging in drug delivery. In this review, we present state-of-the-art research in drug delivery, gene delivery, antimicrobial polymers, and bioactive polymers alongside data-driven developments in drug design and organic synthesis. From this insight, important lessons are revealed for the polymer therapeutics community including the value of a closed loop design-build-test-learn workflow. This is an exciting time as researchers will gain the ability to fully explore the polymer structural landscape and establish quantitative structure-property relationships (QSPRs) with biological significance. (c) 2020 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available